Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

2 trials in Phase 3/4

Results Transparency

0 of 13 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

9(64.3%)

Phase 2

3(21.4%)

Phase 3

2(14.3%)

14Total

Phase 1(9)

Phase 2(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT00448110Phase 3Completed

Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery

Role: lead

NCT00805090Phase 1Completed

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Role: lead

NCT00509743Phase 1Completed

Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium

Role: lead

NCT00548678Phase 1Completed

Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers

Role: lead

NCT00662883Phase 1Completed

Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)

Role: lead

NCT00520104Phase 1Unknown

Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine

Role: lead

NCT00488787Phase 2Completed

Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain

Role: lead

NCT00474799Phase 1Completed

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)

Role: lead

NCT00388011Phase 2Completed

Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery

Role: lead

NCT00390039Phase 3Completed

Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

Role: lead

NCT00520169Phase 1Completed

Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine

Role: lead

NCT00519987Phase 1Completed

Multiple Dose Pharmacokinetics of Intranasal Ketamine

Role: lead

NCT00474136Phase 1Completed

Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium

Role: lead

NCT00390312Phase 2Completed

Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction

Role: lead

All 14 trials loaded